Dr. Howard Njoo, Canada`s Deputy Chief of Public Health, says vaccines can be admitted to the country before they are approved by Health Canada. However, they will not be distributed to the provinces until they have been approved. While other governments are investing hundreds of millions or billions in vaccine development, Canada has set up $1 billion ($761 million) to buy doses abroad. Meanwhile, Medicago, based in Quebec, worked on a tight budget on its own herbal vaccine. By the time the Speech from the Throne was delivered on September 23, Canada had already entered into more than $1 billion in pre-purchase contracts with five pharmaceutical companies for at least 154 million doses of vaccines, if these vaccine candidates prove effective and safe. Two days later, Canada reached another agreement with another company for more than 20 million more doses, betting on the first candidate for the vaccine. In an online statement, the EU said it was also in talks with Moderna to buy 80 million doses from its vaccine candidate, which should have the opportunity to buy 80 million additional doses. While significant work is underway to develop vaccines to prevent the spread of COVID-19, the Canadian government is also focusing on therapeutic drugs used to treat Canadians infected with the virus. „The best way to end this pandemic and keep Canadians healthy is a safe and effective vaccine. By investing in several vaccine candidates and ensuring that one is distributed from coast to coast, we are taking the necessary steps to get Canadians on the road to recovery from COVID-19. Each phase of a study adds more volunteers on which the drug is being tested, looking for adverse health effects and whether the vaccine pushes a person to develop antibodies that can protect against COVID-19. GSK is a global healthcare company with a particular goal: to help people do more, to feel better, to live longer. GSK is the world`s largest producer of vaccines.
For more information, see www.gsk.com Due to the urgent need for COVID-19 vaccines, an injunction allowed them to speed up the process, including the ability to verify the data on an ongoing basis instead of having completed all trials. Meanwhile, the UK said in a series of online statements that it had seized 355 million doses from seven different vaccine developers. Canada has signed contracts with Moderna, Pfizer, Novavax, Johnson-Johnson and now Sanofi and GlaxoSmithKline, all of the most promising vaccines, but none have completed all the necessary clinical trials or been approved for use in Canada. In addition to the recombinant protein vaccine in collaboration with GSK, Sanofi is developing a messenger RNA vaccine in collaboration with Translate Bio. MSA is considered one of the most promising, with several innovative vaccine platforms currently under study across the industry. Preclinical data show that two m NSA vaccines induced high levels of neutralizing antibodies, comparable to those seen in infected individuals. Sanofi expects the Phase 1/2 study to begin in November, with the first possible approval in the second half of 2021. Translate Bio has established mNR production capabilities and Sanofi expects it to be able to provide an annual capacity of 90 to 360 million doses. Canada has chosen to participate in both components of the COVAX program.
The first is that any country can join for access to vaccines, and the second is a fund for rich countries to help low-income countries participate. „We are proud to contribute to our country`s vaccine supply with a vaccine from Canada and would like to thank the Canadian government for its confidence in Medicago,“ said Dr.